Connect with us


BC's latest coronavirus update: Rolling average continues to drop | CTV News – CTV News Vancouver



Vancouver –

B.C. health officials announced 549 new cases of COVID-19 and just one related death in their final pandemic update of the week Friday.

The latest numbers, released in a written statement from the Ministry of Health, bring B.C.’s rolling seven-day average for daily cases to 479, down slightly from Thursday.

This continues the recent trend in declining cases. On Thursday, provincial health officer Dr. Bonnie Henry presented modelling data showing transmission of the novel coronavirus is flat or declining across B.C. 

As of Friday, there are 4,483 active cases of COVID-19 in the province. That total includes 441 people who are hospitalized with the disease, 129 of them in intensive care.


Three new outbreaks have been declared since the province’s last update on Thursday, one of them in an independent-living home in Fraser Health and the other two in schools in the Interior.

The new health-care outbreak is at Bethshan Gardens in Surrey. The two schools now dealing with outbreaks are at King’s Christian School in Salmon Arm and Vernon Christian School in Vernon.

An outbreak at West Shore Laylum assisted-living facility in Surrey has ended. B.C. currently has 37 active outbreaks of COVID-19 in its health-care system.


On Thursday, Henry described B.C.’s slow decline in cases as “a fragile balance” attributable to the province’s high vaccination rates and the additional public health measures put in place to slow the spread of the highly infectious Delta variant of the virus.

As of Friday, 90.2 per cent of eligible B.C. residents ages 12 and older had received at least a first dose of a COVID-19 vaccine; 85.7 per cent of that age group had received both shots.

Henry said the province’s “stubbornly high rates of hospitalization” have been health officials’ “biggest challenge” over the last few months.

Data she presented Thursday showed that an unvaccinated person is 50 times more likely to be hospitalized with COVID-19 than a fully vaccinated person of the same age.

The unvaccinated are also 46 times more likely to die of COVID-19 than people of their age who are fully vaccinated, according to the province.


The new infections announced Friday were spread throughout the province, with the largest number seen in Fraser Health, which added 184 new cases.

Interior Health saw 110 new infections, Northern Health saw 102, Vancouver Coastal Health saw 78 and Island Health saw 73. There were also two new cases among people who normally reside outside Canada.

On a per-capita basis, Northern Health continues to have the highest rate of new cases in the province, with 34 infections per 100,000 residents.

Other health authorities have much larger populations, meaning smaller portions of their population have been testing positive each day, even though some of them have recorded a larger number of cases than Northern Health.

The numbers of new cases added per-capita in the other four health authorities on Friday follow.

  • Interior Health: 13.5 cases per 100,000
  • Fraser Health: 9.5 cases per 100,000
  • Island Health: 8.5 cases per 100,000
  • Vancouver Coastal Health: 6.3 cases per 100,000 

Adblock test (Why?)

Source link

Continue Reading


Australia regulator approves Pfizer vaccine for children 5-11



Australia‘s medicine regulator on Sunday provisionally approved the Pfizer Inc coronavirus vaccine for children between the ages of 5 and 11, with the health minister saying the rollout could begin from Jan. 10.

The Therapeutics Goods Administration “have made a careful, thorough assessment, determined that it is safe and effective and that it is in the interests of children and Australians for children 5 to 11 to be vaccinated,” said Health Minister Greg Hunt.

After initial delays with its general COVID-19 inoculation programme, Australia has swiftly become one of the world’s most-vaccinated countries, with nearly 88% of Australians over the age of 16 having received two doses.

The high vaccination has helped slow the spread of the virus and promote a speedy economic recovery, with the government planning to raise its 2022 growth forecast within weeks.

The efficacy of vaccines against the new Omicron variant, which is spreading in Australia, remains unknown.

The most populous state, New South Wales, reported two more Omicron cases on Sunday, bringing the total to 15 cases, and the Australian Capital Territory confirmed its second.

Parliament House was closed over the weekend to the public until further notice after a staffer to a member of parliament tested positive to COVID-19 after the legislature’s final sitting week of the year on Friday.

The variant of that infection case has not been disclosed, but health authorities said the staff was fully vaccinated.

While nationwide vaccinations are voluntary, states and territories have mandated shots for many occupations, and some require full vaccination to access most hospitality services and non-essential retail.

Australia’s overall childhood immunisation coverage is also one of the highest in the world, with 95% of 5-year-olds inoculated with vaccines recommended for their age, health data showed.

The Pfizer vaccine for those children still needs the approval of the Australian Technical Advisory Group on Immunisation. Once approved, it will be available to about 2.3 million children in the 5-to-11 age group.

Despite battling many outbreaks this year, leading to months of lockdown in Sydney and Melbourne – Australia’s largest cities – the country has had only about 834 confirmed COVID-19 cases and 7.9 deaths per 100,000 people, according to the World Health Organisation, a fraction of the toll in many other developed nations.

Australia has had just under 217,000 cases in total and 2,042 deaths.


(Reporting by Lidia Kelly; Editing by Jonathan Oatis and William Mallard)

Continue Reading


UK study finds mRNA COVID-19 vaccines provide biggest booster impact – Fiji Times



LONDON (Reuters) -COVID-19 vaccines made by Pfizer and Moderna that use mRNA technology provide the biggest boost to antibody levels when given 10-12 weeks after the second dose, a new British study has found.

The “COV-Boost” study was cited by British officials when they announced that Pfizer and Moderna were preferred for use in the country’s booster campaign, but the data has only been made publicly available now.

The study found that six of the seven boosters examined enhanced immunity after initial vaccination with Pfizer-BioNTech’s vaccine, while all seven increased immunity when given after two doses of AstraZeneca’s vaccine.

“A third dose will be effective for many of the vaccines we’ve tested and in many different combinations,” Professor Saul Faust, an immunologist at the University of Southampton and the trial’s lead, told reporters.

The study, published late on Thursday, found that a full dose or half dose of Pfizer or a full dose of Moderna gave a strong boost to both antibody and T-cell levels, regardless of whether the person initially received Pfizer or AstraZeneca.

“All four of the vaccination regimes most widely deployed in the UK lead to essentially the same levels of immunity and are likely to be equally effective,” said Professor Eleanor Riley, immunologist at the University of Edinburgh. She added that a policy change in booster gaps was also supported by the data.

“These data support the JCVI (vaccine committee) decision earlier this week to bring forward booster doses to 3 months after the second vaccination.”

When AstraZeneca, Novavax, Johnson & Johnson and Curevac were given as boosters, they increased antibody levels for either initial vaccine, albeit to a smaller degree, the study found. However, while Valneva boosted antibodies in people initially vaccinated with AstraZeneca, it did not provide a boost for Pfizer.

The COV-Boost study pre-dated the spread of the emergent Omicron variant of concern, and Faust said he had shared samples with the UK Health Security Agency to generate data on Omicron.

The study did however find that booster shots also helped to generate a broad T-cell response against the Beta and Delta variants, which may play a key role in longer-term protection.

A separate study by Imperial College London into how initial exposure to SARS-CoV-2 shapes immune responses, also published late on Thursday, similarly found a good T-cell response to both Alpha and Delta after infection followed by vaccination.

Adblock test (Why?)

Source link

Continue Reading


Dutch former queen Beatrix tests positive for COVID-19



Dutch former queen Beatrix, 83, has tested positive for COVID-19, the royal information service RVD said in a statement Saturday.

Princess Beatrix, as she has been known since her abdication in 2013, got tested after coming down with “mild cold symptoms”, the statement said.

“The princess is at home in isolation and adheres to the rules of life for people who have tested positive,” it added.

The Netherlands has been experiencing a record-breaking wave of COVID-19 cases that is threatening to overwhelm the country’s healthcare system.

(Reporting by Stephanie van den Berg; Editing by Alex Richardson)

Continue Reading